Jon Duke, MD, MS
Dr. Duke is Director of the Center for Health Analytics and Informatics at Georgia Tech Research Institute and Principal Research Scientist at Georgia Tech College of Computing. Prior to working at GeorgiaTech, he directed Regenstrief’s Drug Safety Informatics Lab and led the Merck-Regenstrief Partnership for Healthcare Research and Innovation. Dr. Duke graduated from Harvard Medical School and completed his residency in internal medicine at Brigham and Women’s Hospital. He completed a National Library of Medicine fellowship in Medical Informatics and holds a master’s in Human-Computer Interaction. He is also fluent in Japanase and served as Fulbright Scholar to Japan.
Dr. Duke’s research focuses on applications of big data and human computer interaction to support medication safety. His projects range from predictive modeling of adverse drug events to advanced clinical decision support systems. He has spoken at the FDA on multiple occasions and has received an award for his research on visualization of drug safety information. Dr. Duke has also overseen the development of Regenstrief Institute’s next-generation EMR system and has spoken nationally and internationally on innovation in EMRs. Dr. Duke has been awarded over $15 million in grants and contracts from sources including the National Institutes of Health, National Science Foundation, and pharmaceutical and health IT industry partners. Dr. Duke’s research has resulted in numerous academic publications and been featured in a variety of popular media such as the New York Times, Consumer Reports, and National Public Radio.
Boyce RD, Ryan PB, Noren GN, et al. Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest. Drug Saf. 2014 Jul 2;2:2.
Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013 Oct;36(Suppl 1):S33-47. doi: 10.1007/s40264-013-0097-8.